Every Vertex template ships with section structure, production-grade Word formatting, and draftable example text. Tailored to sponsor branding on delivery. Designed to work together as a coherent suite, not eight unrelated documents.
Why example text matters. The hardest part of regulatory writing is the first draft. Writers stare at instructional placeholders — "describe X here" — and lose hours generating text that's already been written, in some form, a thousand times before. Vertex templates ship with concrete plug-and-play prose so writers refine and adapt instead of authoring from scratch.
And it isn't generic. Every line of example text is grounded in decades of regulatory medical writing experience — what survives FDA review, what triggers information requests, and what reviewers actually accept. The phrasing is what works in real submissions, not what reads cleanly in isolation.
Each template below ships as a Word document with structure, formatting, automation tooling, and concrete example text in every major section. Suite coherence means content reuses cleanly across documents — protocol language flows into the CSR, IB pharmacology flows into Module 2.6, safety narratives flow into Module 2.7.4.
Vertex protocol template covers all M11 sections from synopsis through full body. Example text is included throughout. Numbering and cross-references hold across amendments.
The Investigator's Brochure is one of the most consequential documents in a clinical program — it tells investigators whether to enroll the first subject and signals to reviewers and IRBs whether a trial is safe to begin. Vertex's IB template ships with example text across all sections so writers spend their time refining judgments, not staring at instructional placeholders.
Module 2.5 is the document FDA reviewers read first. Vertex template scaffolds the seven 2.5 sections with example text that links cleanly to 2.7 source detail. Benefit-risk language ships in current FDA-acceptable phrasing — neither over-claiming on efficacy nor under-stating safety signals.
Module 2.7 is where writers most often misplace content. Vertex template enforces the four-section split with example text that shows the difference between a 2.7.2 PK summary and a 2.7.1 biopharmaceutics summary — a distinction frequently muddled in first-time submissions. Tables and listings cross-reference into Module 5 source CSRs.
Vertex CSR template ships with body sections, appendices structure (16.1 through 16.4), and TLF integration points. Example text in efficacy results, safety results, and discussion sections. Designed so that 2.7.3 and 2.7.4 source language can be lifted directly without rewriting.
Vertex narrative template handles SAEs, deaths, AEs leading to discontinuation, AEs of special interest, and protocol-defined narrative triggers. Subject identifier fields, AE timeline, concomitant medications, and investigator causality assessment language all ship pre-drafted. Tracks cleanly to MedDRA terminology.
Coming: automated narrative drafting from your TLF data — runnable in your own environment so clinical data never leaves your systems. Sponsors and CROs choose the integration depth that fits their compliance posture.
Vertex DSUR template covers all 20 ICH E2F sections with example text throughout. Designed to consume content from the IB and Module 2.7.4 without manual restructuring, so each year's DSUR builds on the last instead of starting over.
FDA correspondence is the document type sponsors most often draft from a blank page — meeting requests, briefing books for Type A/B/C/D meetings, and responses to FDA information requests are usually written by hand from scratch. Vertex covers all of them with templated structure and example text for question phrasing, response framing, and supporting-document organization. Faster turnaround on tight FDA deadlines, fewer iterations on agency-acceptable language.
Vertex iPSP template ships with age-stratified scaffolding — neonates, infants, children, adolescents — so writers don't reinvent the stratification structure each time. Formulation development, extrapolation justifications, and timing-relative-to-adult-studies sections all carry example text aligned to current FDA Office of Pediatric Therapeutics expectations.
Three downloadable samples pulled from the commercial Vertex suite.
Table, listing, and figure shells with sponsor-acceptable headers and source-data linkage.
DownloadFull IB template, all seven sections, with example text and Reference Safety Information structure.
DownloadFull ICH M11-aligned protocol template with example text across all sections.
DownloadDemo focuses on whichever document type matters to you — protocol, IB, CSR, Module 2 — not a generic walkthrough.